← Open Payments lookup

NPI 1104904275: Open Payments

NPI 1104904275. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,192 in 53 payments from 19 companies in 2025. Trend: 2023 $1,385 · 2024 $1,270 · 2025 $1,192

Food & beverage: $1,192
CompanyPaymentsAmount
ABBVIE INC.7$159
Novo Nordisk Inc7$135
Lilly USA, LLC5$121
PFIZER INC.5$109
Collegium Pharmaceutical, Inc.5$104
Exact Sciences Corporation3$76
Verity Pharmaceuticals Inc.4$66
Salix Pharmaceuticals, a division of Bausch Health US, LLC3$59
Edwards Lifesciences Corporation1$51
Takeda Pharmaceuticals U.S.A., Inc.2$49

Products named: Belbuca, NURTEC ODT, JARDIANCE, VRAYLAR, Tlando, Cologuard Collection Kit, Edwards SAPIEN 3 Ultra Transcatheter Heart Valve, Wegovy.